IGFBP3 Antibodies

Santa Cruz Biotechnology features a diverse variety of IGFBP3 monoclonal antibodies for research focused on understanding Insulin-like Growth Factor Binding Protein 3. IGFBP3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).IGFBP3 plays a crucial role in regulating the availability of insulin-like growth factors (IGFs) in the extracellular environment, influencing cell growth, differentiation, and apoptosis. IGFBP3 is implicated in various physiological processes and has been associated with several diseases, including cancer and metabolic disorders. Understanding IGFBP3 function is essential for elucidating its potential as a biomarker and therapeutic target. Researchers worldwide rely on IGFBP3 monoclonal antibodies to advance their studies in cell biology and disease mechanisms. The specificity and reliability of IGFBP3 monoclonal antibodies enable precise detection and analysis in complex biological samples. Current research utilizing IGFBP3 monoclonal antibodies continues to reveal new insights into cellular signaling pathways and disease progression. Santa Cruz Biotechnology monoclonal antibodies contribute to advancing scientific knowledge and therapeutic development in the research community.